Elantas Beck Share Price & Earnings Call Analysis

Financials of Elantas Beck

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Elantas Beck

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +169173163174177191184197206210217215222
Expenses +134138126138139153150162166170169170179
Operating Profit36353736383933354040474543
OPM %21%20%23%20%21%20%18%18%20%19%22%21%20%
Other Income +8151217151712109187143
Interest0000000000000
Depreciation3333334555666
Profit before tax40474749495242404453495340
Tax %26%25%25%25%25%20%25%26%26%26%25%25%23%
Net Profit +30353537374231303339363931
EPS in Rs37.9144.6843.9346.6746.5652.7939.1937.5141.4649.5645.7449.6639.20

Financials of Elantas Beck

Profit & Loss

Annual income statement trend

Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025TTM
Sales +341344365383409394383522645680749848864
Expenses +299282287304344340313444535537604676689
Operating Profit4262797865547078110143144172175
OPM %12%18%22%20%16%14%18%15%17%21%19%20%20%
Other Income +8689311822253253554842
Interest0000000011111
Depreciation56567712121212152122
Profit before tax4562818189648091129184183199195
Tax %30%32%33%32%26%22%23%27%24%25%24%26%
Net Profit +324254556650626798137140148146
EPS in Rs39.8752.6868.7369.4882.9962.5177.9084.36123.34173.19176.04186.41184.16
Dividend Payout %11%9%7%6%5%8%6%6%4%3%4%4%

Financials of Elantas Beck

Balance Sheet

Capital structure and asset base

Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Equity Capital888888888888
Reserves1281642142703313764344975917248591,000
Borrowings +000000000000
Other Liabilities +57647070767295114119149148158
Total Liabilities1922362913484154565366187178811,0151,166
Fixed Assets +4545364070110103989899223240
CWIP1051501018191317198
Investments3064109139174160218261356517379592
Other Assets +116126140154171176198240250247395326
Total Assets1922362913484154565366187178811,0151,166

Financials of Elantas Beck

Cash Flows

Operating, investing and financing cash movement

Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Cash from Operating Activity +31465651334879298313363127
Cash from Investing Activity +19-42-51-45-32-40-69-33-76-13278-194
Cash from Financing Activity +-51-4-5-5-4-5-4-4-5-5-5-6
Net Cash Flow-2002-346-82-3136-74
Free Cash Flow274051311036633786121-8296
CFO/OP107%107%104%96%80%118%136%60%103%120%71%97%

Financials of Elantas Beck

Ratios

Working capital efficiency and return ratios

Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Debtor Days535953707557676158556260
Inventory Days8485100757477899573687871
Days Payable5564737371561038667817661
Cash Conversion Cycle828080717877547064416470
Working Capital Days585555626959465748335656
ROCE %35%40%41%33%23%18%19%17%22%28%23%21%

Others in Chemicals & Petrochemicals this season

  • Solar Industries India Ltd (Q1 FY27)

    EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…

  • Sudarshan Chemical Industries Ltd (Q1 FY27)

    The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…

  • Indo Borax & Chemicals Ltd (Q1 FY27)

    250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…

  • SRF Ltd (Q1 FY27)

    Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…

Compare:vs Solar Industries India Ltdvs Pidilite Industries Ltdvs SRF Ltd